Expert Pitch

Preparing Pets for Post-Quarantine Life

Cornell University
8-May-2020 10:05 AM EDT, by Cornell University

With stay-at-home orders put in place during the pandemic, our four-legged friends have been getting some extra time with their owners. As some states start to ease restrictions, this change in the daily schedule is apt to trigger anxiety in pets, particularly in dogs.

Dr. Katherine Houpt, professor emeritus of behavior medicine at the Cornell University College of Veterinary Medicine offer advice on how to prepare pets for post-quarantine life.

Bio: https://www.vet.cornell.edu/research/faculty/katherine-houpt-vmd-phd

Houpt says:

“The shelter-in-place rules have been in place long enough that your pet has become accustomed to your company all the time. While we are all eager to return to our pre-quarantine life, there may be a downside: dogs may be anxious when you leave the house without them. They may express this anxiety by barking, by destroying things and by eliminating.

“In order to reduce the probability of this happening there are a few things you can do to ‘vaccinate’ your dog against separation anxiety.

“The first step is to teach your dog to stay. You will know that they have grasped the concept when you can leave the room and they stay sitting quietly even while you’re in another room. At this point you can practice leaving them by going out the door and remaining outside for five minutes. Be sure to reward your dog with a small treat.

“When you are heading out for your first day back at work, it would be best to give them a brisk walk or a game of fetch before you leave. Before you leave be sure to leave a long-lasting treat such as a rawhide or a Kong toy with frozen melted cheese inside. When you come home don’t greet them until they are calm and not jumping on you or running in circles.

“There are medications for dogs with separation anxiety which our veterinarian can prescribe, but it would be best to prevent the problem from arising.”




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.3632